South & Central America Lyophilization Services for Biopharmaceuticals Market Forecast to 2028 - Regional Analysis

Description

List of Tables

The South & Central America lyophilization services for biopharmaceuticals market was valued at US$ 70.02 million in 2023 and is expected to reach US$ 104.37 million by 2028; it is estimated to grow at a CAGR of 8.3% from 2023 to 2028.

Rapid Growth in Contract Manufacturing and Lyophilization Services Fuels the South & Central America Lyophilization Services for Biopharmaceuticals Market

The biopharmaceuticals market continues to expand across the world, which can be the primary growth driver for the pharmaceutical industry. Biopharmaceutical parenteral manufacturing has expanded recently as more therapeutic biologics have been approved. Biotechnology companies outsource from contract manufacturing organizations (CMOs) to meet their fill-and-finish needs and reduce the risk of microbial contamination. Biopharma companies are dependent on contract manufacturing organizations (CMOs) to provide capacity and capabilities as needed; in some cases, CMOs provide a great deal of a company's production.

Setting up in-house lyophilization capabilities and operations requires specialized equipment and expertise, which is an expensive and time-consuming. However, outsourcing is cheaper and increases the efficiency of manufacturing processes. Additionally, it allows biotechnology companies to redirect resources to other areas. Thus, drug developers and biopharmaceutical companies outsource such operations to CMOs to save overall production and yield cost. A few years ago, the CMO industry was a niche service market, offering additional manufacturing capacity or specific services to biotechnology companies. Now, many biotechnology companies outsource various services, from early-stage drug development to commercial-scale manufacturing. As the biotechnology industry is shifting from large-scale production to niche and targeted therapies (personalized medicine), the demand for flexible operational capabilities, production scales, and multiple-product operations is rising. Owing to all these factors, the inclination toward CMOs is growing. Thus, the rising capability and availability of biopharma CMOs fuel the South & Central America lyophilization service for biopharmaceuticals market growth.

South & Central America Lyophilization Services for Biopharmaceuticals Market Overview

South and Central America region consist of Brazil, Argentina, and the Rest of the South and Central America. Brazil is expected to have a major market share in this region. The market is likely to have good growth opportunities owing to the huge investment for research and development in the pharmaceutical and biopharmaceutical industry. In addition, the collaboration with foreign authorities and organizations is likely to demand the lyophilization services in the countries.

South & Central America Lyophilization Services for Biopharmaceuticals Market Revenue and Forecast to 2028 (US$ Mn)

South & Central America Lyophilization Services for Biopharmaceuticals Market Segmentation

The South & Central America lyophilization services for biopharmaceuticals market is segmented service type, end user, and country.

Based on service type, the South & Central America lyophilization services for biopharmaceuticals market is segmented into lyophilization cycle development, clinical manufacturing, commercial manufacturing, and freeze drying analytical services. The commercial manufacturing segment held the largest market share in 2023.

Based on end-user, the South & Central America lyophilization services for biopharmaceuticals market is segmented into pharmaceutical & biotechnology companies, research institutes, and other. The pharmaceutical & biotechnology companies segment held the largest market share in 2023.

Based on country, the South & Central America lyophilization services for biopharmaceuticals market is segmented into Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the South & Central America lyophilization services for biopharmaceuticals market share in 2023.

ABB, Azbil Corporation, Curia Global Inc, Grifols S.A., Jubilant HollisterStier LLC., and OPTIMA are some of the leading companies operating in the South & Central America lyophilization services for biopharmaceuticals market.

Product Code: BMIRE00029408

1. Introduction

1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
- 1.3.1 South & Central America Lyophilization Services for Biopharmaceuticals Market - by Service Type
- 1.3.2 South & Central America Lyophilization Services for Biopharmaceuticals Market - by End User
- 1.3.3 South & Central America Lyophilization Services for Biopharmaceuticals Market - by Country

2. South & Central America Lyophilization Services for Biopharmaceuticals Market - Key Takeaways

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. South & Central America Lyophilization Services for Biopharmaceuticals Market - Market Landscape

4.1 Overview
4.2 South & Central America PEST Analysis
4.3 Expert's Opinion

5. South & Central America Lyophilization Services for Biopharmaceuticals Market - Key Market Dynamics

5.1 Market Driver
- 5.1.1 Rising Demand for Lyophilized Products
- 5.1.2 Rapid Growth in Contract Manufacturing and Lyophilization Services
5.2 Market Restraints
- 5.2.1 Demerits Associated with Lyophilization Process
5.3 Market Opportunities
- 5.3.1 Launch of Advanced Lyophilization Technology
5.4 Future Trends
- 5.4.1 Growing Number of siRNA and Antibody-Based Formulations
5.5 Impact Analysis of Drivers and Restraints

6. Lyophilization Services for Biopharmaceuticals Market - South & Central America Analysis

6.1 South & Central America Lyophilization Services for Biopharmaceuticals Market Revenue Forecast and Analysis

7. South & Central America Lyophilization Services for Biopharmaceuticals Market Analysis and Forecast to 2028 - by Service Type

7.1 Overview
7.2 South & Central America Lyophilization Services for Biopharmaceuticals Market, by Service Type 2022 & 2028 (%)
7.3 Commercial Manufacturing
- 7.3.1 Overview
- 7.3.2 Commercial Manufacturing: South & Central America Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
7.4 Clinical Manufacturing
- 7.4.1 Overview
- 7.4.2 Clinical Manufacturing: South & Central America Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
7.5 Lyophilization Cycle Development
- 7.5.1 Overview
- 7.5.2 Lyophilization Cycle Development: South & Central America Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
7.6 Freeze Drying Analytical Services
- 7.6.1 Overview
- 7.6.2 Freeze Drying Analytical Services: South & Central America Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)

8. South & Central America Lyophilization Services for Biopharmaceuticals Market Analysis and Forecast to 2028 - by End User

8.1 Overview
8.2 South & Central America Lyophilization Services for Biopharmaceuticals Market, by End User, 2022 & 2028 (%)
8.3 Pharmaceutical and Biotechnology Companies
- 8.3.1 Overview
- 8.3.2 Pharmaceutical and Biotechnology Companies: South & Central America Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
8.4 Research Institutes
- 8.4.1 Overview
- 8.4.2 Research Institutes: South & Central America Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
8.5 Others
- 8.5.1 Overview
- 8.5.2 Others: South & Central America Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)

9. South & Central America Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 - Country Analysis

9.1 Overview
- 9.1.1 South & Central America Lyophilization Services for Biopharmaceuticals Market, by Country, 2022 & 2028 (%)
  - 9.1.1.1 Brazil: South & Central America Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
    - 9.1.1.1.1 Overview
    - 9.1.1.1.2 Brazil: South & Central America Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
    - 9.1.1.1.3 Brazil: South & Central America Lyophilization Services for Biopharmaceuticals Market, by Service Type, 2020-2028 (US$ Million)
    - 9.1.1.1.4 Brazil: South & Central America Lyophilization Services for Biopharmaceuticals Market, by End User, 2020-2028 (US$ Million)
  - 9.1.1.2 Argentina: South & Central America Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
    - 9.1.1.2.1 Overview
    - 9.1.1.2.2 Argentina: South & Central America Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
    - 9.1.1.2.3 Argentina: South & Central America Lyophilization Services for Biopharmaceuticals Market, by Service Type, 2020-2028 (US$ Million)
    - 9.1.1.2.4 Argentina: South & Central America Lyophilization Services for Biopharmaceuticals Market, by End User, 2020-2028 (US$ Million)
  - 9.1.1.3 Rest of South & Central America: South & Central America Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
    - 9.1.1.3.1 Overview
    - 9.1.1.3.2 Rest of South & Central America: South & Central America Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
    - 9.1.1.3.3 Rest of South & Central America: South & Central America Lyophilization Services for Biopharmaceuticals Market, by Service Type, 2020-2028 (US$ Million)
    - 9.1.1.3.4 Rest of South & Central America: South & Central America Lyophilization Services for Biopharmaceuticals Market, by End User, 2020-2028 (US$ Million)

10. South & Central America Lyophilization Services for Biopharmaceuticals Market - Industry Landscape

10.1 Overview
10.2 Growth Strategies in the South & Central America Lyophilization Services for Biopharmaceuticals Market
10.3 Inorganic Growth Strategies
- 10.3.1 Overview
10.4 Organic Growth Strategies
- 10.4.1 Overview

11. Company Profiles

11.1 ABB
- 11.1.1 Key Facts
- 11.1.2 Business Description
- 11.1.3 Products and Services
- 11.1.4 Financial Overview
- 11.1.5 SWOT Analysis
- 11.1.6 Key Developments
11.2 Azbil Corporation
- 11.2.1 Key Facts
- 11.2.2 Business Description
- 11.2.3 Products and Services
- 11.2.4 Financial Overview
- 11.2.5 SWOT Analysis
- 11.2.6 Key Developments
11.3 Curia Global Inc
- 11.3.1 Key Facts
- 11.3.2 Business Description
- 11.3.3 Products and Services
- 11.3.4 Financial Overview
- 11.3.5 SWOT Analysis
- 11.3.6 Key Developments
11.4 Jubilant HollisterStier LLC.
- 11.4.1 Key Facts
- 11.4.2 Business Description
- 11.4.3 Products and Services
- 11.4.4 Financial Overview
- 11.4.5 SWOT Analysis
- 11.4.6 Key Developments
11.5 Optima Pharma GmbH
- 11.5.1 Key Facts
- 11.5.2 Business Description
- 11.5.3 Products and Services
- 11.5.4 Financial Overview
- 11.5.5 SWOT Analysis
- 11.5.6 Key Developments
11.6 Grifols SA
- 11.6.1 Key Facts
- 11.6.2 Business Description
- 11.6.3 Products and Services
- 11.6.4 Financial Overview
- 11.6.5 SWOT Analysis
- 11.6.6 Key Developments

12. Appendix

12.1 About The Insight Partners
12.2 Glossary of Terms